FSA
IDXX icon

Franklin Street Advisors’s Idexx Laboratories IDXX Stock Holding History

Franklin Street Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Sell
26,215
-540
-2% -$303K 0.77% 44
2026
Q1 		$15M Sell
26,755
-13,428
-33% -$8.61M 0.92% 36
2025
Q4 		$27.2M Buy
40,183
+3,469
+9% +$2.36M 1.55% 21
2025
Q3 		$23.5M Buy
36,714
+1,583
+5% +$961K 1.35% 28
2025
Q2 		$18.8M Buy
35,131
+3,222
+10% +$1.54M 1.17% 32
2025
Q1 		$13.4M Buy
+31,909
New +$13.9M 0.95% 38
2024
Q3 		– Sell
-7,693
Closed -$3.75M – 170
2024
Q2 		$3.75M Sell
7,693
-30,967
-80% -$15.5M 0.27% 59
2024
Q1 		$20.9M Sell
38,660
-4,406
-10% -$2.41M 1.54% 20
2023
Q4 		$23.9M Sell
43,066
-1,288
-3% -$605K 1.96% 19
2023
Q3 		$19.4M Sell
44,354
-3,974
-8% -$1.98M 1.72% 20
2023
Q2 		$24.3M Buy
48,328
+4,989
+12% +$2.39M 2.06% 18
2023
Q1 		$21.7M Buy
43,339
+29,879
+222% +$14.3M 1.97% 18
2022
Q4 		$5.49M Buy
+13,460
New +$5.22M 0.52% 56
2022
Q3 		– Sell
-708
Closed -$248K – 141
2022
Q2 		$248K Sell
708
-22,706
-97% -$9.26M 0.02% 128
2022
Q1 		$12.8M Buy
23,414
+93
+0.4% +$48.9K 1.03% 36
2021
Q4 		$15.4M Buy
23,321
+190
+0.8% +$119K 1.16% 36
2021
Q3 		$14.4M Sell
23,131
-2,298
-9% -$1.54M 1.22% 29
2021
Q2 		$16.1M Sell
25,429
-2,571
-9% -$1.42M 1.36% 26
2021
Q1 		$13.7M Sell
28,000
-717
-2% -$359K 1.27% 30
2020
Q4 		$14.4M Sell
28,717
-916
-3% -$410K 1.39% 26
2020
Q3 		$11.6M Sell
29,633
-1,055
-3% -$390K 1.25% 32
2020
Q2 		$10.1M Sell
30,688
-3,961
-11% -$1.15M 1.2% 34
2020
Q1 		$8.39M Sell
34,649
-6,473
-16% -$1.69M 1.22% 31
2019
Q4 		$10.7M Sell
41,122
-1,785
-4% -$470K 1.27% 30
2019
Q3 		$11.7M Sell
42,907
-4,595
-10% -$1.28M 1.47% 22
2019
Q2 		$13.1M Buy
47,502
+1,402
+3% +$345K 1.68% 20
2019
Q1 		$10.3M Buy
46,100
+1,105
+2% +$228K 1.44% 25
2018
Q4 		$8.37M Buy
44,995
+357
+0.8% +$73.2K 1.32% 31
2018
Q3 		$11.1M Sell
44,638
-8,482
-16% -$2.06M 1.51% 23
2018
Q2 		$11.6M Buy
53,120
+4,125
+8% +$850K 1.69% 15
2018
Q1 		$9.38M Buy
48,995
+2,275
+5% +$420K 1.41% 25
2017
Q4 		$7.31M Buy
46,720
+3,730
+9% +$587K 1.09% 41
2017
Q3 		$6.68M Buy
42,990
+19,785
+85% +$3.13M 1.1% 40
2017
Q2 		$3.75M Buy
23,205
+715
+3% +$116K 0.64% 56
2017
Q1 		$3.48M Sell
22,490
-650
-3% -$89.6K 0.61% 59
2016
Q4 		$2.71M Sell
23,140
-22,435
-49% -$2.56M 0.48% 64
2016
Q3 		$5.14M Sell
45,575
-4,791
-10% -$505K 0.93% 44
2016
Q2 		$4.68M Sell
50,366
-2,825
-5% -$243K 0.89% 43
2016
Q1 		$4.17M Buy
53,191
+5,451
+11% +$393K 0.82% 40
2015
Q4 		$3.48M Buy
47,740
+2,765
+6% +$197K 0.69% 44
2015
Q3 		$3.34M Buy
+44,975
New +$3.22M 0.66% 46

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

Franklin Street Advisors's IDXX Position: Q2 2026 in Review

Franklin Street Advisors reduced its Idexx Laboratories (IDXX) stake by 2% in Q2 2026, selling an estimated $303K and leaving 26,215 shares worth $13.8M. The position accounts for 0.77% of the portfolio, ranked #44.

Franklin Street Advisors first reported a position in IDXX in Q3 2015 and has held it in 41 quarters since. The position peaked at $27.2M in Q4 2025. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Franklin Street Advisors held 26,215 shares of Idexx Laboratories worth $13.8M as of Q2 2026.
  • Franklin Street Advisors sold 540 Idexx Laboratories shares in Q2 2026, an estimated $303K.
  • Idexx Laboratories made up 0.77% of Franklin Street Advisors's portfolio in Q2 2026, its #44 holding.
  • Franklin Street Advisors first reported a position in Idexx Laboratories in Q3 2015 and has held it in 41 quarters since.
  • Franklin Street Advisors's Idexx Laboratories position peaked at $27.2M in Q4 2025.
  • 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.